《美股業績》Oreo生產商億滋(MDLZ.US)季績及盈測勝預期 市後股價上揚
生產Oreo餅乾及吉伯利朱古力等零食的美國食品巨擘億滋國際(Mondelez International)(MDLZ.US),公布去年第四季業績。季度純利5.83億美元,按年跌41.9%。每股季度攤薄純利42美仙,經調整後為73美仙,超出市場預期。季度淨收益86.95億美元,按年升13.5%,高於市場預期的83.3億美元。毛利率按年跌1.6個百分點至35.4%。
公司預期今年全年每股經調整盈利將錄高單位數增長,市場預期為3.11美元,按年升6%。公司亦預期撇除併購等影響,今年淨收入自然增長介乎5%至7%。
億滋國股價在延長交易時段升1.6%,報66.5美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.